| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.051 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |